Medicare Negotiations of Drug Pricing
Medicare negotiations of drug pricing
POINT: If it had the authority to negotiate drug prices with pharmaceutical manufacturers, Medicare would achieve significant savings.
COUNTERPOINT: The ability of Medicare to negotiate with drug companies directly will not substantially reduce drug costs and will, ...
Looks like you are not subscribed to have access to full content on this book.
Please login or subscribe to get access.
If your Institution does not have a subscription and you cannot access the full text of content on the site, find out how your Institution can subscribe.